3TZB | Oxidoreductase | date | Sep 27, 2011 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Quinone Oxidoreductase (Nq02) Bound To Nsc13000 | ||||||||||||||
authors | M.S.Dunstan, D.Leys | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Ribosyldihydronicotinamide Dehydrogenase [Quinone Chain: A, B, C, D Synonym: Nrh Dehydrogenase [Quinone] 2, Nrh:Quinone Oxidore Quinone Reductase 2, Qr2; Ec: 1.10.99.2 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Nqo2, Nmor2 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.19 Å | ||||||||||||
ligand | AA, FAD, ZN | enzyme | Oxidoreductase E.C.1.10.99.2 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-kappaB signaling., Nolan KA, Dunstan MS, Caraher MC, Scott KA, Leys D, Stratford IJ, Mol Cancer Ther. 2012 Jan;11(1):194-203. doi: 10.1158/1535-7163.MCT-11-0543. Epub, 2011 Nov 16. PMID:22090421 |
Data retrieval |
View 3TZB in 3D |
Visual 3D analysis of 3TZB |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3TZB |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |